A case series on the use of atypical long acting injectables as first-line antipsychotic treatment : Who benefits and how?

Jaafar, NRNNRNJaafarZakaria, HHZakariaMidin, MMMidinYs, CCYs2024-05-292024-05-2920121461-1457WOS:000209062500214https://oarep.usim.edu.my/handle/123456789/11108en-USA case series on the use of atypical long acting injectables as first-line antipsychotic treatment : Who benefits and how?Meeting Abstract595915